Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Am J Surg Pathol ; 45(10): 1303-1313, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34232606

ABSTRACT

Sex cord-stromal tumors (SCSTs) account for the second most common category of testicular neoplasms and include several entities that may show overlapping morphologies and present diagnostic challenges. We analyzed a cohort of 120 testicular SCSTs and investigated the diagnostic utility of SRY-box transcription factor 9 (SOX9), forkhead box protein L2 (FOXL2), and steroidogenic factor 1 (SF-1) immunohistochemical stains. The results were compared with the more commonly used SCST markers, inhibin α, calretinin, and Wilms' tumor 1 (WT1). SF-1 was overall the most sensitive stain (91%), followed by inhibin α (70%), calretinin (52%), FOXL2 (50%), SOX9 (47%), and WT1 (37%), but sensitivities varied by tumor type. SOX9 and calretinin were more commonly positive in sex cord elements versus stromal elements (62% vs. 27% and 47% vs. 9%, respectively), whereas FOXL2 was more commonly positive in stromal elements versus sex cord elements (100% vs. 55%) when excluding Leydig cell tumors from the stromal category. Although no individual stain was diagnostically specific, some immunophenotypic patterns were noted that may help in the subclassification of SCSTs. We conclude that SOX9, FOXL2, and SF-1 are useful immunohistochemical stains for confirming sex cord-stromal differentiation in testicular tumors and provide increased sensitivity as well as additional diagnostic information, especially when combined with the more commonly used inhibin α, calretinin, and WT1 immunostains. Although morphology is paramount for subclassification of SCSTs, knowledge of certain immunohistochemical patterns may be helpful for diagnostically challenging cases.


Subject(s)
Biomarkers, Tumor/analysis , Forkhead Box Protein L2/analysis , Immunohistochemistry , SOX9 Transcription Factor/analysis , Sex Cord-Gonadal Stromal Tumors/chemistry , Steroidogenic Factor 1/analysis , Testicular Neoplasms/chemistry , Animals , Calbindin 2/analysis , Humans , Inhibins/analysis , Male , Predictive Value of Tests , Sex Cord-Gonadal Stromal Tumors/pathology , Testicular Neoplasms/pathology , WT1 Proteins/analysis
2.
Pediatr Dev Pathol ; 24(1): 27-33, 2021.
Article in English | MEDLINE | ID: mdl-32988294

ABSTRACT

BACKGROUND: Rare nodules of heterotopic adrenocortical and hepatic tissue are reported in the placenta. A mechanism for adrenocortical tissue in the placenta has been perplexing, while hepatic tissue is generally considered related to yolk sac primordia. The clear cell morphology of these nodules is similar to the adrenal cortex of the adult; however, the fetal adrenal gland does not usually display clear cells. METHODS: We stained 9 placental nodules, histologically identical to "adrenocortical" heterotopia of the placenta, to determine whether adrenocortical differentiation could be confirmed. These cases include 3 archival cases initially diagnosed as "adrenocortical" heterotopia. RESULTS: Immunohistochemical staining with steroid factor-1 (SF-1), HepPar-1, and Arginase-1 showed that these nodules of clear cells are actually hepatic (SF-1 negative, HepPar-1, and Arginase-1 positive). PAS staining suggests that glycogen accumulation is responsible for the clear cytoplasm. In contrast, a nodule of adrenocortical heterotopia near the testis and the adrenal gland from a 38-week-old neonatal autopsy case confirm SF-1 reactivity as expected. CONCLUSION: We propose that adrenocortical heterotopia in the placenta is a misnomer, and that these subchorionic nodules of clear cells demonstrate hepatic differentiation.


Subject(s)
Adrenal Cortex , Choristoma/metabolism , Immunohistochemistry , Liver , Placenta Diseases/metabolism , Placenta/chemistry , Antigens, Neoplasm/analysis , Arginase/analysis , Biopsy , Cell Differentiation , Choristoma/pathology , Diagnosis, Differential , Female , Humans , Placenta/pathology , Placenta Diseases/pathology , Predictive Value of Tests , Pregnancy , Steroidogenic Factor 1/analysis
3.
Endocr Pathol ; 31(2): 150-155, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32193825

ABSTRACT

With the introduction of the WHO 2017 classification of endocrine neoplasms, the use of the pituitary transcription factors PIT-1, Tpit and SF-1 has become the standard of care. However, immunohistochemistry for these transcription factors is not available in all institutions, and their reliability has been questioned. We read with interest the findings of Mete et al. that GATA-3 expression was detected in some pituitary neuroendocrine tumours (PitNET). We therefore sort to validate this in our large cohort of PitNETs. We searched the database of Royal North Shore Hospital for PitNETs between 1998 and 2012, constructed a tissue microarray and reclassified these entities based on their expression for PIT-1, Tpit and SF-1. We then scored the expression of GATA-3 immunohistochemistry on a scale of 0-2, where 0 was no staining, 1 was patchy or weak staining and 2 was strong and diffuse staining. 265 of 346 tumours were able to be classified into a specific tumour subtype, and 263 tumours had tissue available for GATA-3 immunohistochemistry. 89% of gonadotrophs and 93% of triple-negative tumours with expression for luteinising hormone and follicle-stimulating hormone were positive for GATA-3. In the triple-negative group, GATA-3 was positive in 1 mammosomatotroph and 80% of tumours with thyroid-stimulating hormone expression. In the triple-negative hormone-negative group, 21 of 33 tumours were positive (64%). The results demonstrate that GATA-3 is a useful marker to supplement the existing pituitary transcription factors, albeit slightly less sensitive and specific than previously reported. GATA-3 may be employed in addition to the current array of immunohistochemical transcription factors, especially in the resource poor setting. However, given its potential cross-reactivity with other entities of the Sella, positive staining should be interpreted with caution and in the morphological and clinical context.


Subject(s)
Biomarkers, Tumor/analysis , GATA3 Transcription Factor/biosynthesis , Neuroendocrine Tumors/classification , Pituitary Neoplasms/classification , GATA3 Transcription Factor/analysis , Homeodomain Proteins/analysis , Homeodomain Proteins/biosynthesis , Humans , Steroidogenic Factor 1/analysis , Steroidogenic Factor 1/biosynthesis , T-Box Domain Proteins/analysis , T-Box Domain Proteins/biosynthesis , Transcription Factor Pit-1/analysis , Transcription Factor Pit-1/biosynthesis
4.
Am J Surg Pathol ; 43(8): 1123-1128, 2019 08.
Article in English | MEDLINE | ID: mdl-31094926

ABSTRACT

Evaluation of testicular biopsies from azoospermic men requires recognition of phases of germ cell maturation as organized architecturally within the seminiferous tubule, as well as distinguishing the inability to generate mature spermatozoa (germ cell aplasia or maturation arrest) from normal spermatogenesis, which may be associated with a reversible obstruction. While traditional fixatives (eg, Bouin solution) provide exquisite nuclear detail and preserve the architectural integrity of the seminiferous tubule, formalin fixation yields biopsies with relatively poor nuclear detail and frequent luminal sloughing of cells, making it difficult to assess sperm maturation. One clone of the anti-DOG1 antibody was recently found to be expressed in late (postspermatogonial) germ cells. We developed a dual stain including DOG1 and SF-1 to mark late germ cells and Sertoli cells, respectively, in both sloughed and intact cells. Consecutive testicular biopsies (N=28) from men with azoospermia were classified by hematoxylin and eosin morphology and stained with a dual SF-1 (Perseus)/DOG1 (Cell Marque) immunohistochemical stain. Histologic patterns included normal spermatogenesis (5 cases), hypospermatogenesis (5 cases), late maturation arrest (2 cases), Sertoli cell only pattern (15 cases), and extensive tubular hyalinization (1 case). Architectural disruption of seminiferous tubules with sloughing of cells into the lumens was noted in all biopsies, at least focally. SF-1 (nuclear) was expressed in sloughed Sertoli cells; DOG1 (cytoplasmic) in sloughed postspermatogonial germ cells (spermatocytes and spermatids). This resulted in two distinct immunophenotypes: SF-1(+)/DOG1(-) sloughed cells in cases with the Sertoli cell only pattern and SF-1(+)/DOG1(+) sloughed cells in all other histologic patterns (normal spermatogenesis, hypospermatogenesis, and maturation arrest). Because the rate of sperm retrieval is lower in men with the Sertoli cell only pattern, this immunohistochemical stain may assist pathologists in the proper interpretation of testicular biopsies, allowing better-informed decision making by patients and clinicians regarding the subsequent use of assisted reproductive technologies.


Subject(s)
Anoctamin-1/analysis , Azoospermia/metabolism , Immunohistochemistry , Neoplasm Proteins/analysis , Sertoli Cells/chemistry , Spermatozoa/chemistry , Steroidogenic Factor 1/analysis , Testis/chemistry , Adult , Azoospermia/pathology , Azoospermia/physiopathology , Biomarkers/analysis , Biopsy , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis , Sertoli Cells/pathology , Spermatogenesis , Spermatozoa/pathology , Testis/pathology , Testis/physiopathology
5.
J Pediatr Surg ; 54(9): 1906-1912, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30686519

ABSTRACT

BACKGROUND: Adrenocortical tumors (ACT) are uncommon in the pediatric age group. Using the standard Weiss criteria in pediatric tumors leads to overdiagnosis. This has led to the development of newer systems such as Weineke criteria. Ki67 labeling index aids in differentiating adenomas from carcinomas. We aim to evaluate the diagnostic and prognostic role of Ki67 labeling index, along with immunoexpression of steroidogenic factor-1, insulin like growth factor 2 and p57, in pediatric ACTs diagnosed using Weineke criteria. METHODS: We have studied 25 cases of pediatric ACTs. Immunohistochemical staining for Ki67, SF-1, IGF2 and p57 was done in all cases and the result was correlated with the morphological diagnosis using the Weineke criteria. RESULTS: Ki67 labeling index showed complete concordance with the morphological diagnosis. SF-1 and IGF2 showed similar correlation with the diagnosis, with IGF-2 proving to be a more specific marker. Increased Ki67, SF-1 and IGF2 immunostaining also correlated with worse survival. p57 was more specific in determining benign status of a tumor. CONCLUSION: SF-1 and IGF2 are highly sensitive markers of malignancy in pediatric ACTs and can be used in combination with Ki67 expression for optimal diagnostic and prognostic assessment of pediatric ACTs. TYPE OF STUDY: Prognosis study. LEVEL OF EVIDENCE: Level II.


Subject(s)
Adrenal Cortex Neoplasms , Adrenal Cortex , Cyclin-Dependent Kinase Inhibitor p57 , Insulin-Like Growth Factor II , Steroidogenic Factor 1 , Adrenal Cortex/chemistry , Adrenal Cortex/metabolism , Adrenal Cortex/pathology , Adrenal Cortex Neoplasms/chemistry , Adrenal Cortex Neoplasms/diagnosis , Adrenal Cortex Neoplasms/metabolism , Adrenal Cortex Neoplasms/pathology , Biomarkers, Tumor/analysis , Biomarkers, Tumor/metabolism , Child , Cyclin-Dependent Kinase Inhibitor p57/analysis , Cyclin-Dependent Kinase Inhibitor p57/metabolism , Humans , Immunohistochemistry , Insulin-Like Growth Factor II/analysis , Insulin-Like Growth Factor II/metabolism , Prognosis , Steroidogenic Factor 1/analysis , Steroidogenic Factor 1/metabolism
6.
Endocrinology ; 159(3): 1401-1415, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29370380

ABSTRACT

Prenatal dexamethasone exposure (PDE) induces multiorgan developmental toxicities in offspring. Here we verified the transgenerational inheritance effect of ovarian developmental toxicity by PDE and explored its intrauterine programming mechanism. Pregnant rats subcutaneously received 0.2 mg/kg/d dexamethasone from gestational day (GD) 9 to GD20. A subgroup was euthanized for fetuses on GD20, and the other group went on to spontaneous labor to produce F1 offspring. The adult F1 females were mated with normal males to produce the F2 and F3 generations. The PDE fetal rats exhibited ovarian mitochondrial structural abnormalities, decreased serum estradiol (E2) levels, and lower expression levels of ovarian steroidogenic factor 1 (SF1), steroidal synthetases, and insulinlike growth factor 1 (IGF1). On postnatal week (PW) 6 and PW12, the PDE F1 offspring showed altered reproductive behavior and ovarian morphology. The serum E2 level and ovarian expression of SF1, steroidal synthetases, and IGF1 were also decreased. The adult F3 offspring showed alterations in reproductive phenotype and ovarian IGF1, SF1, and steroidal synthetase expression similar to those of F1. PDE induces ovarian developmental toxicity and transgenerational inheritance effects. The mechanism by which this toxicity occurs may be related to PDE-induced low-functional programming of fetal ovarian IGF1/SF1 and steroidal synthetases.


Subject(s)
Dexamethasone/toxicity , Ovary/drug effects , Ovary/embryology , Prenatal Exposure Delayed Effects , Animals , Dexamethasone/blood , Estradiol/blood , Female , Fetal Blood/chemistry , Insulin-Like Growth Factor I/analysis , Male , Mitochondria/pathology , Ovary/chemistry , Pedigree , Phenotype , Pregnancy , Rats , Rats, Wistar , Reproduction/drug effects , Specific Pathogen-Free Organisms , Steroidogenic Factor 1/analysis , Steroids/biosynthesis
7.
Am J Surg Pathol ; 42(2): 141-149, 2018 02.
Article in English | MEDLINE | ID: mdl-29240582

ABSTRACT

Sertoliform cystadenoma of the rete testis (SCRT) is rare with only 9 cases reported to date in the literature, none with follow-up. Four large genitourinary pathology consult services were searched. We identified 15 cases of SCRT. Men were 21 to 84 years old (mean, 46 y) and had testicular discomfort or mass. Other findings were seminoma (n=1), spermatocele (n=2), hydrocele (n=1), varicocele (n=1), and scrotal hematoma (n=1). Eight had preoperative serum tumor markers, which were normal. Tumors ranged from 0.3 to 4 cm (mean, 1.5 cm). All of them were well circumscribed with solid and cystic features and occupied on average, 73% of the rete (20% to 100%). The tumors were mostly confined within dilated channels of the rete testis and showed classic features consisting of: (1) tubules with well-formed lumina in 87% of cases; (2) well-formed tubules with no lumina in 87% of cases; and (3) cords/nests in hyalinized or myxoid stroma in 73% of cases. Other patterns included: (1) solid/sheet growth in 26% of cases; (2) individual cells in 13% of cases; (3) festoons in 13% of cases; (4) branching tubules in 7% of cases; and (5) papillary in 7% of cases. Cells were cuboidal with round to oval nuclei with small nucleoli, except at the periphery where projections into rete tubules had a more columnar appearance. In the festooning pattern, nuclei were pseudostratified and columnar with prominent nucleoli and nuclear grooves. In 4 cases, tumor extended into adjacent seminiferous tubules surrounded by dense peritubular fibrosis, with in some cases small cysts lined by flattened epithelium containing pale lightly granular material. All cases lacked necrosis and significant atypia. Mitoses ranged from 0 to 2 per 10 high-power field. Follow-up ranged from 4 to 170 months with mean of 97 months. For the 13 cases with information, all patients were alive, except for 3 who died of either unrelated causes (9.2 and 10 y) or of unknown cause (4.8 y at age 89 y). We performed immunohistochemistry for steroidogenic factor 1 and inhibin in 4 of our cases, where 3 (75%) were positive for both markers. We also describe 2 additional cases which morphologically resembled SCRT but had more atypical features. This study highlights that SCRT has variable morphology. We also verify the benign nature of the lesion and its lack of association with any syndromes.


Subject(s)
Cystadenoma/pathology , Rete Testis/pathology , Sertoli Cell Tumor/pathology , Testicular Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Biopsy , Cystadenoma/chemistry , Cystadenoma/therapy , Humans , Immunohistochemistry , Inhibins/analysis , Italy , Male , Middle Aged , Mitotic Index , Rete Testis/chemistry , Sertoli Cell Tumor/chemistry , Sertoli Cell Tumor/therapy , Steroidogenic Factor 1/analysis , Testicular Neoplasms/chemistry , Testicular Neoplasms/therapy , Tumor Burden , United States , Young Adult
8.
Int J Gynecol Pathol ; 35(2): 167-75, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26352548

ABSTRACT

Female adnexal tumors of probable wolffian origin (FATWOs) are rare. They can closely mimic endometrioid adenocarcinomas with a prominent spindle cell component and Sertoli cell tumors (SCTs). To further define their immunohistochemical profile and origin, we investigated the expression of PAX-8, PAX-2, and GATA binding protein 3 (GATA-3) (wolffian markers) and of steroidogenic factor-1 (SF-1) (sex-cord stromal marker) in FATWOs. We also studied the expression of PAX-8 and PAX-2 in endometrioid adenocarcinomas; of SF-1 in Sertoli-Leydig cell and SCTs; and of PAX-8, PAX-2, GATA-3, and SF-1 in rete ovarii-a proposed site of origin for FATWOs. A database search yielded 8 FATWOs, 18 ovarian/tubal/paraovarian endometrioid adenocarcinomas, and 8 ovarian Sertoli-Leydig cell and SCTs. Eleven cases with rete ovarii sections were included. Of the FATWOs studied, all were negative for PAX-8, PAX-2, GATA-3, and SF-1. Of the endometrioid adenocarcinomas studied, PAX-8 was positive in all and PAX-2 was positive in 57%. Of the Sertoli-Leydig cell and SCTs, all were positive for SF-1 except one. The rete ovarii were positive for PAX-8, weakly positive for SF-1, and negative for PAX-2 and GATA-3. Our study suggests that PAX-8 and SF-1 can be helpful in the distinction between FATWOs and endometrioid adenocarcinomas and SCTs, respectively. Our results do not support a Mullerian or sex-cord stromal or rete ovarii origin for FATWOs. It is curious, however, that FATWOs do not express wolffian markers-it is possibly related to their origin from a distinctive portion of the wolffian duct.


Subject(s)
Adenoma/diagnosis , Adnexal Diseases/diagnosis , Biomarkers, Tumor/analysis , Diagnosis, Differential , PAX8 Transcription Factor/biosynthesis , Steroidogenic Factor 1/biosynthesis , Adult , Carcinoma, Endometrioid/diagnosis , Female , Humans , Immunohistochemistry , Middle Aged , PAX8 Transcription Factor/analysis , Sertoli Cell Tumor/diagnosis , Steroidogenic Factor 1/analysis
9.
PLoS One ; 10(12): e0145968, 2015.
Article in English | MEDLINE | ID: mdl-26717016

ABSTRACT

Preeclampsia (PE) is a multisystem disorder unique to Homo sapiens that is known to cause maternal and perinatal mortality and morbidity. Between 5-7% of all pregnancies are affected by PE and it is responsible for approximately 50,000 maternal deaths annually. The pathogenesis of PE remains poorly understood. However, the results of this study indicated that insufficient decidualization plays a significant role. NR5A1 and NR5A2 are orphan members of the Ftz-F1 subfamily of nuclear receptors and are involved in mammal follicular development, female reproduction, steroidogenesis, and decidualization. The expression of NR5A1 and NR5A2 in the human decidua and their functions during decidualization were investigated using in vitro cultured cells by real-time PCR, immunohistochemistry, western blotting, and siRNA techniques. The results demonstrated that the levels of NR5A2 mRNA and protein in the decidual tissues of women with PE were lower than those of normal pregnant women. However, the levels of NR5A1 mRNA and protein did not significantly differ between groups. The expression of NR5A2 was upregulated after in vitro decidualization, but the expression of NR5A1 remained low and showed no difference compared with that of the control cells. Knocking down of NR5A2 in human endometrial stromal cells (hESC) resulted in a significant reduction in their expression of decidualization markers (IGFBP1 and PRL) and signaling pathway molecules (WNT4 and BMP2) (P < 0.05). From these data, we concluded that NR5A2 is pivotal for the decidualization of decidual tissues and cultured human endometrial stromal cells. Disorders of the endometrium in decidual tissues may be associated with the abnormal decidualization thought to cause PE.


Subject(s)
Decidua/metabolism , Pre-Eclampsia/etiology , Receptors, Cytoplasmic and Nuclear/physiology , Adult , Blotting, Western , Case-Control Studies , Decidua/chemistry , Decidua/physiology , Endometrium/cytology , Female , Gene Knockdown Techniques , Humans , In Vitro Techniques , Pregnancy , Real-Time Polymerase Chain Reaction , Receptors, Cytoplasmic and Nuclear/analysis , Receptors, Cytoplasmic and Nuclear/metabolism , Steroidogenic Factor 1/analysis , Steroidogenic Factor 1/physiology
10.
Braz. j. med. biol. res ; 48(12): 1087-1094, Dec. 2015. graf
Article in English | LILACS | ID: lil-762914

ABSTRACT

During gonad and adrenal development, the POD-1/capsulin/TCF21transcription factor negatively regulates SF-1/NR5A1expression, with higher SF-1 levels being associated with increased adrenal cell proliferation and tumorigenesis. In adrenocortical tumor cells, POD-1 binds to the SF-1 E-box promoter region, decreasing SF-1 expression. However, the modulation of SF-1 expression by POD-1 has not previously been described in normal adrenal cells. Here, we analyzed the basal expression of Pod-1 and Sf-1 in primary cultures of glomerulosa (G) and fasciculata/reticularis (F/R) cells isolated from male Sprague-Dawley rats, and investigated whether POD-1 overexpression modulates the expression of endogenous Sf-1 and its target genes in these cells. POD-1 overexpression, following the transfection of pCMVMycPod-1, significantly decreased the endogenous levels of Sf-1 mRNA and protein in F/R cells, but not in G cells, and also decreased the expression of the SF-1 target StAR in F/R cells. In G cells overexpressing POD-1, no modulation of the expression of SF-1 targets, StAR and CYP11B2, was observed. Our data showing that G and F/R cells respond differently to ectopic POD-1 expression emphasize the functional differences between the outer and inner zones of the adrenal cortex, and support the hypothesis that SF-1 is regulated by POD-1/Tcf21 in normal adrenocortical cells lacking the alterations in cellular physiology found in tumor cells.


Subject(s)
Animals , Male , Adrenal Cortex/metabolism , Basic Helix-Loop-Helix Transcription Factors/metabolism , Phosphoproteins/metabolism , Steroidogenic Factor 1/metabolism , Adrenal Cortex/cytology , Basic Helix-Loop-Helix Transcription Factors/genetics , Electrophoresis, Polyacrylamide Gel , Gene Expression , Immunoblotting , Primary Cell Culture , Phosphoproteins/analysis , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , RNA, Messenger/analysis , Steroidogenic Factor 1/analysis , Zona Fasciculata/cytology , Zona Fasciculata/metabolism , Zona Glomerulosa/cytology , Zona Glomerulosa/metabolism , Zona Reticularis/cytology , Zona Reticularis/metabolism
11.
Braz J Med Biol Res ; 48(12): 1087-94, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26421867

ABSTRACT

During gonad and adrenal development, the POD-1/capsulin/TCF21transcription factor negatively regulates SF-1/NR5A1expression, with higher SF-1 levels being associated with increased adrenal cell proliferation and tumorigenesis. In adrenocortical tumor cells, POD-1 binds to the SF-1 E-box promoter region, decreasing SF-1 expression. However, the modulation of SF-1 expression by POD-1 has not previously been described in normal adrenal cells. Here, we analyzed the basal expression of Pod-1 and Sf-1 in primary cultures of glomerulosa (G) and fasciculata/reticularis (F/R) cells isolated from male Sprague-Dawley rats, and investigated whether POD-1 overexpression modulates the expression of endogenous Sf-1 and its target genes in these cells. POD-1 overexpression, following the transfection of pCMVMycPod-1, significantly decreased the endogenous levels of Sf-1 mRNA and protein in F/R cells, but not in G cells, and also decreased the expression of the SF-1 target StAR in F/R cells. In G cells overexpressing POD-1, no modulation of the expression of SF-1 targets, StAR and CYP11B2, was observed. Our data showing that G and F/R cells respond differently to ectopic POD-1 expression emphasize the functional differences between the outer and inner zones of the adrenal cortex, and support the hypothesis that SF-1 is regulated by POD-1/Tcf21 in normal adrenocortical cells lacking the alterations in cellular physiology found in tumor cells.


Subject(s)
Adrenal Cortex/metabolism , Basic Helix-Loop-Helix Transcription Factors/metabolism , Phosphoproteins/metabolism , Steroidogenic Factor 1/metabolism , Adrenal Cortex/cytology , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Electrophoresis, Polyacrylamide Gel , Gene Expression , Immunoblotting , Male , Phosphoproteins/analysis , Primary Cell Culture , RNA, Messenger/analysis , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Steroidogenic Factor 1/analysis , Zona Fasciculata/cytology , Zona Fasciculata/metabolism , Zona Glomerulosa/cytology , Zona Glomerulosa/metabolism , Zona Reticularis/cytology , Zona Reticularis/metabolism
12.
Pathologe ; 36(3): 301-9, 2015 May.
Article in German | MEDLINE | ID: mdl-25941097

ABSTRACT

In daily routine pathology of the adrenal glands three tumor entities are important: adrenocortical tumors, adrenomedullary tumors and metastases. The differentiation of these three main tumor types can often be difficult structurally but immunostaining enables a definite diagnosis in nearly all cases. Adrenocortical tumors are positive for steroidogenic factor 1 and melan-A and always negative for chromogranin A whereas adrenomedullary tumors express chromogranin A but never keratin. A broad spectrum of antibodies is available for the identification of metastases and even the rare epithelioid angiosarcomas. For adrenocortical tumors, adenomas and carcinomas can be differentiated using three scoring systems and the Ki-67 index in adenomas should not exceed 3%. Using scoring systems and the Ki-67 index approximately 90% of cortical tumors can be differentiated into benign or malignant tumors. For pheochromocytomas two scoring systems are used for differentiating benign and malignant tumors but the results are less dependable.


Subject(s)
Adrenal Gland Neoplasms/pathology , Adrenal Glands/pathology , Adrenal Cortex Neoplasms/pathology , Adrenal Gland Neoplasms/classification , Adrenal Gland Neoplasms/secondary , Adrenal Medulla/pathology , Adrenocortical Adenoma/classification , Adrenocortical Adenoma/pathology , Biomarkers, Tumor/analysis , Chromogranin A/analysis , Humans , Keratins/analysis , MART-1 Antigen/analysis , Pheochromocytoma/classification , Pheochromocytoma/pathology , Steroidogenic Factor 1/analysis
13.
Endocr Pathol ; 25(4): 366-70, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25252621

ABSTRACT

Adrenocortical carcinoma is a rare malignancy. Medical treatment including op'DDD or mitotane with or without platinum-based cytotoxic chemotherapy is frequently administered to the patients in an adjuvant setting following surgery or in advanced disease, because of aggressive clinical behavior in some cases. Potential roles of pathologists in determining the clinical algorithm of medical therapy are histopathological confirmation of adrenocortical carcinoma, both malignant features using the criteria of Weiss and adrenocortical origin applying immunohistochemistry of steroid factor-1 (SF-1); providing the relevant pathological information to determine the precise pathological stage in individual patients; and providing the accurate Ki67 labeling index of the patients. There are no established pathological surrogate markers for response to mitotane or op' DDD therapy available at this juncture but as in other malignancies, Ki67 LI could provide information as to the potential clinical response to platinum-based cytotoxic chemotherapy. Epidermal growth factor receptor (EGFR) is significantly overexpressed in adrenocortical carcinoma but the absence of gene mutations could limit the therapeutic application of anti-EGFR antibody and/or EGFR tyrosine kinase inhibitor in the patients.


Subject(s)
Adrenal Cortex Neoplasms/pathology , Adrenocortical Carcinoma/drug therapy , Adrenocortical Carcinoma/pathology , Biomarkers, Tumor/analysis , Adrenal Cortex Neoplasms/drug therapy , Antineoplastic Agents, Hormonal/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Mitotane/administration & dosage , Pathology, Molecular/methods , Predictive Value of Tests , Steroidogenic Factor 1/analysis
15.
Pathol Res Pract ; 209(8): 503-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23866946

ABSTRACT

Factors controlling benign and malignant adrenocortical tumorigenesis are largely unknown, but several mouse models suggest an important role for inhibin-alpha (INHA). To show that findings in the mouse are relevant to human tumors and clinical outcome, we investigated the expression of signaling proteins and transcription factors involved in the regulation of INHA in human tumor samples⋅ Thirty-one adrenocortical tumor samples, including 13 adrenocortical carcinomas (ACCs), were categorized according to Weiss score, hormonal profile, and patient survival data and analyzed using immunohistochemistry and RT-PCR. Expression of the TGF-ß signaling mediator SMAD3 varied inversely with Weiss score, so that SMAD3 expression was lowest in the most malignant tumors. By contrast, SMAD2 expression was upregulated in most malignant tumors. Wnt pathway co-receptors LRP5 and LRP6 were predominantly expressed in benign adrenocortical tumors. In ACCs, expression of transcription factors GATA-6 and SF-1 correlated with that of their target gene INHA. Moreover, the diminished expression of GATA-6 and SF-1 in ACCs correlated with poor outcome. We conclude that the factors driving INHA expression are reduced in ACCs with poor outcome, implicating a role for INHA as a tumor suppressor in humans.


Subject(s)
Adrenal Cortex Neoplasms/chemistry , Adrenocortical Carcinoma/chemistry , Biomarkers, Tumor/analysis , Transcription Factors/analysis , Transforming Growth Factor beta/analysis , Wnt Proteins/analysis , Wnt Signaling Pathway , Adrenal Cortex Neoplasms/genetics , Adrenal Cortex Neoplasms/mortality , Adrenal Cortex Neoplasms/pathology , Adrenocortical Carcinoma/genetics , Adrenocortical Carcinoma/mortality , Adrenocortical Carcinoma/pathology , Adult , Aged , Biomarkers, Tumor/genetics , Child , Female , GATA6 Transcription Factor/analysis , Humans , Immunohistochemistry , Infant , Inhibins/analysis , Low Density Lipoprotein Receptor-Related Protein-5/analysis , Low Density Lipoprotein Receptor-Related Protein-6/analysis , Male , Middle Aged , Neoplasm Invasiveness , Prognosis , Registries , Reverse Transcriptase Polymerase Chain Reaction , Smad2 Protein/analysis , Smad3 Protein/analysis , Steroidogenic Factor 1/analysis , Survival Analysis , Transcription Factors/genetics , Wnt Proteins/genetics , Wnt Signaling Pathway/genetics , Young Adult , beta Catenin/analysis
16.
Int J Surg Pathol ; 21(2): 121-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22832114

ABSTRACT

Granulosa cell tumors are classified as juvenile and adult types. They may be misinterpreted as a yolk sac tumor when they exhibit a "reticular" growth pattern and contain prominent mitotic activity. In this study, the authors performed immunohistochemical stains for SALL4 and steroidogenic factor-1 (SF-1) on 27 cases of yolk sac tumors and 24 granulosa cell tumors. Nuclear stains for both antibodies were considered as positive and the intensity of staining was graded as negative, weak, moderate, and strong. All the yolk sac tumors were positive for SALL4 (100%) with moderate to strong grade staining and negative for SF-1 (100%). In contrast, all the granulosa cell tumors were positive for SF-1 (85% moderate to strong grade staining and 15% weak staining) and negative for SALL4 (100%). The difference was significant (P < .01, Student's t test). This result indicates that these 2 markers could be used to distinguish these 2 tumors in a difficult situation.


Subject(s)
Biomarkers, Tumor/analysis , Endodermal Sinus Tumor/diagnosis , Granulosa Cell Tumor/diagnosis , Steroidogenic Factor 1/biosynthesis , Transcription Factors/biosynthesis , Adolescent , Adult , Aged , Aged, 80 and over , Diagnosis, Differential , Endodermal Sinus Tumor/metabolism , Female , Granulosa Cell Tumor/metabolism , Humans , Immunohistochemistry , Male , Mediastinal Neoplasms/metabolism , Mediastinal Neoplasms/pathology , Middle Aged , Neoplasm Metastasis/pathology , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Steroidogenic Factor 1/analysis , Testicular Neoplasms/metabolism , Testicular Neoplasms/pathology , Transcription Factors/analysis , Young Adult
17.
Ann Diagn Pathol ; 17(2): 192-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23218904

ABSTRACT

This study aimed to identify an immunohistochemical panel to aid in the differential diagnosis for tumors with clear cell morphology. Twenty-five clear cell renal cell carcinomas (CCRCCs), 19 clear cell ovarian carcinoma (CCOCs), 20 cases of adrenal cortical carcinomas(ACCs), and 10 chordomas were stained for renal cell carcinoma marker (RCC Ma), Pax8, brachyury, and steroidogenic factor 1 (SF-1). The extent of stains was scored as focal (<25%), nonfocal (25%-50%), and diffuse (>50%). The intensity was scored as weak, moderate, and strong. Twenty-two CCRCCs were positive for RCC Ma (88%) and Pax8 (88%), respectively. The RCC Ma cytoplasmic staining was largely diffuse (76%) and strong (76%). The nuclear Pax8 staining was usually diffuse (76%) and moderate (64%) to strong (8%). All of CCRCCs were negative for brachyury and SF-1. All of 19 CCOCs were positive for Pax8 nuclear staining. The staining was diffuse, moderate (21%) to strong (79%). All of CCOCs were negative for RCC Ma, brachyury, and SF-1. All of 20 ACCs were positive for SF-1 nuclear staining. The staining was largely diffuse (95%), moderate (55%) to strong (15%). All of ACC were negative for RCC Ma, Pax8, and brachyury. All of 10 chordomas were positive for brachyury nuclear staining. The staining was diffuse and strong. All of chordomas were negative for RCC Ma, Pax8, and SF-1. In summary, the panel of RCC Ma, Pax8, brachyury, and SF-1 is useful in the differential diagnosis of tumors with clear morphology.


Subject(s)
Adenocarcinoma, Clear Cell/metabolism , Biomarkers, Tumor/analysis , Fetal Proteins/analysis , Paired Box Transcription Factors/analysis , Steroidogenic Factor 1/analysis , T-Box Domain Proteins/analysis , Adrenocortical Carcinoma/metabolism , Carcinoma, Renal Cell/metabolism , Chordoma/metabolism , Female , Humans , Immunohistochemistry , Kidney Neoplasms/metabolism , Male , Ovarian Neoplasms/metabolism , PAX8 Transcription Factor , Retrospective Studies
18.
Endocrine ; 39(3): 212-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21409515

ABSTRACT

The issue of how rapid frequency GnRH pulses selectively stimulate LH transcription is not fully understood. The rat LHß promoter contains two GnRH-responsive regions: the proximal region has binding elements for SF1, and the distal site contains a CArG box, which binds SRF. This study determined whether GnRH stimulates pituitary SF1, DAX1 (an endogenous SF1 inhibitor), and SRF transcription in vivo, and whether regulation is frequency dependent. Male rats were pulsed with 25 ng GnRH i.v. every 30 min or every 240 min for 1-24 h, and primary transcripts (PTs) and mRNAs were measured by real time PCR. Fast frequency GnRH pulses (every 30 min) increased SF1 PT (threefold) within 1 h, and then declined after 6 h. SF1 mRNA also increased within 1 h and remained elevated through 24 h. Fast frequency GnRH also stimulated a transient increase in DAX1 PT (twofold after 1 h) and mRNA (1.7-fold after 6 h), while SRF mRNA rose briefly at 1 h. Slow frequency pulses did not affect gene expression of SF1, DAX1, or SRF. These findings support a mechanistic link between SF1 in the frequency regulation of LHß transcription by pulsatile GnRH.


Subject(s)
DAX-1 Orphan Nuclear Receptor/genetics , Gene Expression Regulation/drug effects , Gonadotropin-Releasing Hormone/administration & dosage , Luteinizing Hormone, beta Subunit/genetics , Pituitary Gland/metabolism , Serum Response Factor/genetics , Animals , DAX-1 Orphan Nuclear Receptor/analysis , Male , Periodicity , Pituitary Gland/chemistry , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Serum Response Factor/analysis , Steroidogenic Factor 1/analysis , Steroidogenic Factor 1/genetics , Transcription, Genetic
19.
Fertil Steril ; 95(8): 2655-7, 2011 Jun 30.
Article in English | MEDLINE | ID: mdl-21324456

ABSTRACT

Steroidogenic factor-1 (SF-1) protein expression was not observed in any form of endometriosis (peritoneal, ovarian, or deep infiltrating endometriosis), which suggests that SF-1 locally produced by endometrial or stromal cells may not play a major role in the development of endometriosis. However, the strong expression of SF-1 in cortical and medullary ovarian mesenchymatous cells may be capable of creating a favorable steroidogenic environment and the development of the disease.


Subject(s)
Endometriosis/metabolism , Endometrium/chemistry , Mesoderm/chemistry , Ovarian Diseases/metabolism , Ovary/chemistry , Peritoneal Diseases/metabolism , Steroidogenic Factor 1/analysis , Stromal Cells/chemistry , Biopsy , Case-Control Studies , Endometriosis/pathology , Endometrium/pathology , Female , Humans , Immunohistochemistry , Mesoderm/pathology , Ovarian Diseases/pathology , Ovary/pathology , Peritoneal Diseases/pathology , Stromal Cells/pathology
20.
Am J Surg Pathol ; 34(3): 423-32, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20154585

ABSTRACT

We have encountered an increasing number of image-guided adrenal mass biopsies in which the differential diagnosis is adrenal cortical lesion versus pheochromocytoma. This distinction is sometimes difficult because of confounding clinical presentations, overlapping morphologies, and some degree of immunophenotypic overlap including focal staining with markers of purported lineage specificity. Interventional radiologists commonly use narrow gauge biopsy needles in this setting, which yield scant diagnostic tissue and further complicate pathologic evaluation. In this study, a detailed immunoprofile of 63 adrenal cortical lesions (3 adrenal rests, 6 adrenal cortical hyperplasias, 43 adrenal cortical adenomas, 4 adrenal cortical neoplasms of uncertain malignant potential, and 7 adrenal cortical carcinomas) was compared with 35 pheochromocytomas using traditional (calretinin, chromogranin, inhibin, melanA, and synaptophysin) and novel [steroidogenic factor-1 (SF-1), microtubule-associated protein 2, and mammalian achaete-scute homolog-1] antibodies, using tissue microarray technology to simulate small image-guided biopsies. Staining extent and intensity were each scored semiquantitatively for each antibody. A comparison of sensitivity and specificity using different intensity thresholds required for a "positive" result (> or = 1+ vs. > or = 2+) was performed. Staining results based on a > or = 1+ and (> or = 2+) intensity threshold were as follows: calretinin-95% (89%) in adrenal cortical lesions and 14% (0%) in pheochromocytomas; chromogranin-0% in adrenal cortical lesions and 100% in pheochromocytomas; inhibin-97% (86%) in adrenal cortical lesions and 6% (0%) in pheochromocytomas; microtubule-associated protein 2-29% (16%) in adrenal cortical lesions and 100% (89%) in pheochromocytomas; mammalian achaete-scute homolog-1-0% in both adrenal cortical lesions and pheochromocytomas; melanA-94% (86%) in adrenal cortical lesions and 6% (0%) in pheochromocytomas; SF-1-87% (86%) in adrenal cortical lesions and 0% in pheochromocytomas; synaptophysin-67% (59%) in adrenal cortical lesions and 100% in pheochromocytomas. Using an antibody panel consisting of chromogranin plus the nuclear antibody SF-1 and either calretinin or inhibin, while requiring a high-staining intensity threshold, helps to eliminate interpretative issues of artifactual or background reactivity, improves diagnostic sensitivity/specificity, and makes for an effective immunohistochemical approach in distinguishing adrenal cortical lesions from pheochromocytomas.


Subject(s)
Adenoma/chemistry , Adrenal Cortex Neoplasms/chemistry , Adrenal Gland Neoplasms/chemistry , Biomarkers, Tumor/analysis , Carcinoma/chemistry , Immunohistochemistry , Pheochromocytoma/chemistry , Tissue Array Analysis , Adenoma/pathology , Adolescent , Adrenal Cortex Neoplasms/pathology , Adrenal Gland Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Artifacts , Biopsy , Calbindin 2 , Carcinoma/pathology , Child , Child, Preschool , Chromogranins/analysis , Diagnosis, Differential , Female , Humans , Infant , Inhibins/analysis , Male , Middle Aged , Pheochromocytoma/pathology , Predictive Value of Tests , S100 Calcium Binding Protein G/analysis , Sensitivity and Specificity , Steroidogenic Factor 1/analysis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...